Xequel Bio is a clinical-stage biopharmaceutical company that focuses on developing innovative therapies using its proprietary alpha-connexin carboxyl-terminus 1 (aCT1) peptide technology platform. This platform is designed to enhance the body's healing response by stabilizing gap and tight junctions, which are crucial for maintaining cellular communication and fluid regulation in tissues. By addressing the disruptions caused by injury, aCT1 aims to reduce harmful inflammation and promote accelerated healing, ultimately leading to improved tissue integrity and recovery. The technology has shown promise across various medical fields, including dermatology, ophthalmology, and pulmonology, with specific formulations like Granexin® Gel for wound healing and iNexin™ Ophthalmic Solution for corneal injuries.

The aCT1 technology platform is backed by extensive preclinical and clinical research, demonstrating its potential to manage inflammation and optimize the body's response to injury. Xequel Bio is committed to addressing unmet medical needs through its innovative approach, with ongoing clinical trials and preclinical studies aimed at validating the efficacy of aCT1 in treating conditions related to skin, eye, and lung injuries. The company’s leadership emphasizes a strong commitment to scientific excellence and innovation, positioning Xequel Bio for future growth and impactful contributions to patient care.

United States

Xequel Bio, Inc. is a clinical stage biopharmaceutical company advancing its proprietary aCT1 (alpha-Connexin carboxyl-Terminal 1 peptide) technology platform to develop drugs that will enable physicians to better manage a variety of indications involving inflammation and the body's response to injury.

aCT1 is a patented new chemical entity currently in development for multiple indications. The Company's lead clinical programs include Granexin® gel in dermatology and iNexinTM ophthalmic solution in ophthalmology. The Company also has ongoing preclinical research in pulmonology.

Xequel Bio

Company Details